Pharmaceutical giant Eli Lilly (NYSE: LLY) on Monday launched a late-stage clinical trial in long-term care facilities for its Covid-19 antibody treatment. The Phase 3…
Pharmaceutical giant Eli Lilly (NYSE: LLY) on Monday launched a late-stage clinical trial in long-term care facilities for its Covid-19 antibody treatment. The Phase 3…